Skip to main content
. 2017 Oct 31;8(70):114839–114844. doi: 10.18632/oncotarget.22214

Table 2. Case-Control Study Showing Association between the 1425G/a SNP in PRKCH and HCM.

Samples Case Control MAF Unadjusted (A/G)
AA AG GG Sum H-W AA AG GG Sum H-W Case Control Odds Ratio 95% CI P Value
Screening
HCM 16 95 206 317 0.250 7 86 233 326 0.775 0.200 0.153 1.383 (1.036, 1.845) 0.028
Obstructive 11 69 144 224 0.468 4 62 165 231 0.505 0.203 0.152 1.427 (1.013, 2.012) 0.046
Non-obstructive 5 22 66 93 0.102 3 24 68 95 0.626 0.172 0.158 1.108 (0.691, 1.718) 0.781